Position in RPRX
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$67,060,041
+$13,003,768 QoQ
Shares Held
1,397,958
-0.1% QoQ
Ownership
0.243%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 59%
Shared 0%
None 41%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Russell Investments Group, Ltd. holds $1,223,802,944 across 266 Biotechnology names. RPRX ranks #3 (5.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
228,086 | $176,228,356 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
367,691 | $164,188,731 | |
| 3 | RPRX |
Royalty Pharma plc
This page
|
1,397,958 | $67,060,041 | |
| 4 | INCY |
Incyte Corp
|
638,242 | $60,071,331 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
147,533 | $48,814,236 | |
| 6 | MRNA |
Moderna, Inc.
|
710,640 | $36,100,509 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
606,224 | $34,245,589 | |
| 8 | INSM |
INSMED Inc
|
169,162 | $27,661,365 |
All Filings in RPRX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $67,060,041 | 1,397,958 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $54,056,273 | 1,398,972 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $49,600,604 | 1,405,913 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $47,100,715 | 1,307,264 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $49,613,651 | 1,593,757 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $47,341,223 | 1,855,791 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $39,782,527 | 1,406,240 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $21,595,946 | 818,959 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $12,213,080 | 402,143 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $9,072,140 | 322,967 | Shares | Defined | 2024-02-05 | |
| 2023-09-30 | $7,275,147 | 268,060 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $9,412,585 | 306,200 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $15,370,682 | 426,608 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $15,074,942 | 381,451 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $15,418,550 | 383,737 | Shares | Defined | 2022-11-04 | |
| 2022-06-30 | $14,153,478 | 336,667 | Shares | Defined | 2022-07-29 | |
| 2022-03-31 | $762,057 | 19,560 | Shares | Defined | 2022-05-05 | |
| 2021-12-31 | $302,062 | 7,580 | Shares | Defined | 2022-01-21 | |
| 2021-09-30 | $289,806 | 8,019 | Shares | Defined | 2021-11-08 | |
| 2021-06-30 | $44,884 | 1,095 | Shares | Defined | 2021-08-04 | |
| 2021-03-31 | $58,886 | 1,350 | Shares | Defined | 2021-05-10 | |
| 2020-12-31 | $6,802,044 | 135,905 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $145,604 | 3,461 | Shares | Defined | 2020-11-09 | |
| No filing history on record for this holder in this stock. | ||||||